Company news
MiNK Therapeutics, Inc. news in 2021
MiNK Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.
MiNK Therapeutics Announces 77% Survival Rate in Intubated Patients with COVID-19 Respiratory Failure Treated with AgenT-797
November 11, 2021
MiNK Therapeutics Presents New Preclinical and Clinical Data on iNKT Cell Therapy Programs at SITC 2021
November 8, 2021
MiNK Therapeutics Announces Closing of Initial Public Offering
October 18, 2021
MiNK Therapeutics, Inc. Announces Pricing of Initial Public Offering
October 13, 2021